Literature DB >> 15987650

Natural controlled HIV infection: preserved HIV-specific immunity despite undetectable replication competent virus.

Nico Kloosterboer1, Paul H P Groeneveld, Christine A Jansen, Teun J K van der Vorst, Fransje Koning, Carel N Winkel, Ashley J Duits, Frank Miedema, Debbie van Baarle, Ronald P van Rij, Kees Brinkman, Hanneke Schuitemaker.   

Abstract

Long-term non-progressive HIV infection, characterized by low but detectable viral load and stable CD4 counts in the absence of antiviral therapy, is observed in about 5% of HIV-infected patients. Here we identified four therapy naïve individuals who are strongly seropositive for HIV-1 but who lack evidence of detectable HIV p24 antigen, plasma RNA, and proviral DNA in routine diagnostic testing. With an ultrasensitive PCR, we established that frequencies of pol proviral DNA sequences were as low as 0.2-0.5 copies/10(6) PBMC. HIV could not be isolated using up to 30x10(6) patient PBMC. One individual was heterozygous for CCR5 Delta32, but CCR5 expression on CD4+ T cells was normal to high in all four individuals. In vitro R5 and X4 HIV-1 susceptibility of CD8-depleted PBMC of all study subjects was significantly lower than the susceptibility of CD8-depleted PBMC of healthy blood donors. All individuals expressed protective HLA-B*58s alleles and showed evidence of HIV-specific cellular immunity either by staining with HLA-B*57 tetramers folded with an HIV RT or gag peptide or after stimulation with HIV-1 p24 gag, RT, or nef peptides in ELIspot analysis. HIV-specific CD4+ T helper cells were demonstrated by proliferation of CD4+ T cells and intracellular staining for IL-2 and IFNgamma after stimulation with an HIV-gag peptide pool. Sera of all individuals showed antibody-mediated neutralization of both R5 and X4 HIV-1 variants. These data implicate that very low-level antigen exposure is sufficient for sustained HIV-specific immunity and suggest the possibility of a multi-factorial control of HIV infection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15987650     DOI: 10.1016/j.virol.2005.06.001

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  11 in total

1.  HLA B*5701-positive long-term nonprogressors/elite controllers are not distinguished from progressors by the clonal composition of HIV-specific CD8+ T cells.

Authors:  Daniel Mendoza; Cassandra Royce; Laura E Ruff; David R Ambrozak; Máire F Quigley; Thurston Dang; Vanessa Venturi; David A Price; Daniel C Douek; Stephen A Migueles; Mark Connors
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

2.  Broadly cross-neutralizing antibodies in HIV-1 patients with undetectable viremia.

Authors:  M Medina-Ramírez; V Sánchez-Merino; S Sánchez-Palomino; A Merino-Mansilla; C B Ferreira; I Pérez; N González; A Alvarez; J M Alcocer-González; F García; J M Gatell; J Alcamí; E Yuste
Journal:  J Virol       Date:  2011-04-06       Impact factor: 5.103

Review 3.  Success and failure of the cellular immune response against HIV-1.

Authors:  Stephen A Migueles; Mark Connors
Journal:  Nat Immunol       Date:  2015-06       Impact factor: 25.606

4.  Coreceptor usage, diversity, and divergence in drug-naive and drug-exposed individuals from Malawi, infected with HIV-1 subtype C for more than 20 years.

Authors:  Ishla Seager; Simon A Travers; Michael D Leeson; Amelia C Crampin; Neil French; Judith R Glynn; Grace P McCormack
Journal:  AIDS Res Hum Retroviruses       Date:  2014-07-29       Impact factor: 2.205

Review 5.  CD8(+)T-cell-mediated control of HIV-1 and SIV infection.

Authors:  Stephanie A Freel; Kevin O Saunders; Georgia D Tomaras
Journal:  Immunol Res       Date:  2011-04       Impact factor: 2.829

6.  Comparison of HIV DNA and RNA in gut-associated lymphoid tissue of HIV-infected controllers and noncontrollers.

Authors:  Hiroyu Hatano; Ma Somsouk; Elizabeth Sinclair; Kara Harvill; Lee Gilman; Michelle Cohen; Rebecca Hoh; Peter W Hunt; Jeffrey N Martin; Joseph K Wong; Steven G Deeks; Steven A Yukl
Journal:  AIDS       Date:  2013-09-10       Impact factor: 4.177

7.  Epidemiologic characteristics and natural history of HIV-1 natural viral suppressors.

Authors:  Mohammad M Sajadi; Neil T Constantine; Dean L Mann; Manhattan Charurat; Elham Dadzan; Peter Kadlecik; Robert R Redfield
Journal:  J Acquir Immune Defic Syndr       Date:  2009-04-01       Impact factor: 3.731

8.  HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype.

Authors:  Asier Sáez-Cirión; Christine Lacabaratz; Olivier Lambotte; Pierre Versmisse; Alejandra Urrutia; Faroudy Boufassa; Françoise Barré-Sinoussi; Jean-François Delfraissy; Martine Sinet; Gianfranco Pancino; Alain Venet
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-11       Impact factor: 11.205

9.  Possible clearance of transfusion-acquired nef/LTR-deleted attenuated HIV-1 infection by an elite controller with CCR5 Δ32 heterozygous and HLA-B57 genotype.

Authors:  John Zaunders; Wayne B Dyer; Melissa Churchill; C Mee Ling Munier; Philip H Cunningham; Kazuo Suzuki; Kristin McBride; Will Hey-Nguyen; Kersten Koelsch; Bin Wang; Bonnie Hiener; Sarah Palmer; Paul R Gorry; Michelle Bailey; Yin Xu; Mark Danta; Nabila Seddiki; David A Cooper; Nitin K Saksena; John S Sullivan; Sean Riminton; Jenny Learmont; Anthony D Kelleher
Journal:  J Virus Erad       Date:  2019-04-01

10.  Cytotoxic capacity of SIV-specific CD8(+) T cells against primary autologous targets correlates with immune control in SIV-infected rhesus macaques.

Authors:  Daniel Mendoza; Stephen A Migueles; Julia E Rood; Bennett Peterson; Sarah Johnson; Nicole Doria-Rose; Douglas Schneider; Eva Rakasz; Matthew T Trivett; Charles M Trubey; Vicky Coalter; Claire W Hallahan; David Watkins; Genoveffa Franchini; Jeffrey D Lifson; Mark Connors
Journal:  PLoS Pathog       Date:  2013-02-28       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.